Guiming Chen
Impact in
-
- MicroRNA in disease regulation
-
- Sepsis Diagnosis and Treatment
- Autophagy in Disease and Therapy
Papers in
-
- MicroRNA in disease regulation 3
-
- Sepsis Diagnosis and Treatment 5
- Co-authors
- Yong Jiang (5 shared papers)Haihua Luo (5 shared papers)Zhanguo Liu (4 shared papers)Shenhai Gong (2 shared papers)Peng Chen (2 shared papers)Hongwei Zhou (2 shared papers)Chenyang Huang (2 shared papers)Ping Chang (3 shared papers)
- Journals
- Medical Oncology (1 paper)JCI Insight (1 paper)Frontiers in Oncology (1 paper)Clinical Science (1 paper)American Journal of Physiology-Gastrointestinal and Liver Physiology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Guiming Chen
27 papers receiving 568 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 52
- Epidemiology 121
- Molecular Biology 212
- Immunology 55
- Pharmacology 26
Countries citing papers authored by Guiming Chen
This map shows the geographic impact of Guiming Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiming Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiming Chen more than expected).
Fields of papers citing papers by Guiming Chen
This network shows the impact of papers produced by Guiming Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiming Chen. The network helps show where Guiming Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Guiming Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 146 | |
| 2 | 2023 | 106 | |
| 3 | 2016 | 67 | |
| 4 | 2020 | 42 | |
| 5 | 2014 | 38 | |
| 6 | 2020 | 19 | |
| 7 | 2016 | 18 | |
| 8 | 2017 | 17 | |
| 9 | 2017 | 17 | |
| 10 | 2018 | 17 | |
| 11 | 2020 | 15 | |
| 12 | 2023 | 12 | |
| 13 | 2022 | 9 | |
| 14 | 2024 | 9 | |
| 15 | 2017 | 7 | |
| 16 | 2020 | 6 | |
| 17 | High-background parenchymal enhancement in the contralateral breast is an imaging biomarker for favorable prognosis in patients with triple-negative breast cancer treated with chemotherapy. | 2021 | 6 |
| 18 | 2014 | 5 | |
| 19 | 2021 | 4 | |
| 20 | 2023 | 4 |
About Guiming Chen
Guiming Chen is a scholar working on Cancer Research, Epidemiology, Immunology, Molecular Biology and Oncology, having authored 29 papers that have together received 575 indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (5 papers), Immune Response and Inflammation (3 papers), MicroRNA in disease regulation (3 papers), Organ Transplantation Techniques and Outcomes (2 papers), Transplantation: Methods and Outcomes (2 papers), Gut microbiota and health (2 papers), Phytochemicals and Antioxidant Activities (1 paper) and Agricultural and Biological Research (1 paper). The work is most often cited by research in Cancer Research (52 citations), Epidemiology (121 citations), Molecular Biology (212 citations), Immunology (55 citations) and Pharmacology (26 citations). Guiming Chen has collaborated with scholars based in China and United States. Frequent co-authors include Yong Jiang, Haihua Luo, Zhanguo Liu, Shenhai Gong, Peng Chen, Hongwei Zhou, Chenyang Huang, Ping Chang, Lei Li and Zhengzheng Yan. Their work appears in journals such as Medical Oncology, JCI Insight, Frontiers in Oncology, Clinical Science and American Journal of Physiology-Gastrointestinal and Liver Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.